Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancer

Joyce A. O'Shaughnessy, Anthony Tolcher, David Riseberg, David Venzon, Jo Anne Zujewski, Marianne Noone, Michelle Gossard, David Danforth, Joan Jacobson, Victoria Chang, Barry Goldspiel, Patricia Keegan, Ruthann Giusti, Kenneth H. Cowan

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds